The evidence
behind the work

My research spans predictive analytics, oncology outcomes, real-world data, and biomarker-driven treatment.

Selected Publications
01
Pertuzumab plus trastuzumab for treatment-refractory HER2-amplified metastatic colorectal cancer: comparison of the MyPathway trial with a real-world external control arm.
JCO Clinical Cancer Informatics
2022
Cover of JCO Clinical Cancer Informatics
02
An innovative approach to alleviating fatigue in metastatic breast cancer patients.
Clinical Cancer Research
2025
03
Natural history of HER2-amplified and HER2 wild-type refractory metastatic colorectal cancer in US clinical practice.
JCO Clinical Cancer Informatics
2022
04
Atezolizumab treatment of tumors with high tumor mutational burden from MyPathway.
Cancer Discovery
2021
05
Pertuzumab and trastuzumab for HER2-positive metastatic biliary tract cancer.
The Lancet Oncology
2021
06
Efficacy of atezolizumab in solid tumors with high tumor mutational burden: a MyPathway study cohort.
Cancer Research
2021
07
Machine-learning algorithms for predicting hospital readmissions in sickle cell disease.
British Journal of Haematology
2020
08
Outcomes of patients with acute myeloid leukemia who relapse after five years of complete remission.
Oncology Research
2020
09
The impact of omitted or inadequately dosed radiotherapy in extranodal natural killer T-cell lymphoma.
Cancer
2017
View the Full ORCID Record
Featured Presentation

Oral Late-Breaking Abstract

Oral Late-Breaking Abstract, ASCO Annual Meeting 2021. Additional presentations at AACR and ASH on tumor mutational burden, HER2-targeted therapy, and predictive machine learning.

View Presentation